Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3513002 | 0.88 | — | — | |
| SCHEMBL12220100 | 0.82 | — | — | |
| SCHEMBL16085952 | 0.77 | APLNR (0.31) | — | |
| SCHEMBL22588562 | 0.73 | — | — | |
| SCHEMBL4698567 | 0.71 | — | — | |
| SCHEMBL30623872 | 0.71 | — | — | |
| SCHEMBL14665205 | 0.71 | F10 (0.33) | — | |
| SCHEMBL14665204 | 0.70 | ARG1 (0.33) | — | |
| SCHEMBL14980230 | 0.69 | — | — | |
| SCHEMBL6130714 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9051234-B2 | Method for producing alkanediol | UBE INDUSTRIES, LTD. (JP) | 2015-06-09 | — | — | US | disclosed |
| US-20140316167-A1 | METHOD FOR PRODUCING ALKANEDIOL | UBE INDUSTRIES, LTD (JP) | 2014-10-23 | — | — | US | disclosed |
| EP-2781498-A1 | METHOD FOR PRODUCING ALKANEDIOL | Ube Industries, Ltd. (JP) | 2014-09-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140316167-A1 | METHOD FOR PRODUCING ALKANEDIOL | ADH1C, ADH5, ADH1A | UGT2B7 727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.